rs794728158
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PM4_Supporting
The NM_004415.4(DSP):βc.5167_5169delβ(p.Glu1723del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,614,046 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β β ).
Frequency
Genomes: π 0.000053 ( 0 hom., cov: 32)
Exomes π: 0.000066 ( 0 hom. )
Consequence
DSP
NM_004415.4 inframe_deletion
NM_004415.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
DSP (HGNC:3052): (desmoplakin) This gene encodes a protein that anchors intermediate filaments to desmosomal plaques and forms an obligate component of functional desmosomes. Mutations in this gene are the cause of several cardiomyopathies and keratodermas, including skin fragility-woolly hair syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_004415.4. Strenght limited to Supporting due to length of the change: 1aa.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.5167_5169del | p.Glu1723del | inframe_deletion | 23/24 | ENST00000379802.8 | |
DSP | NM_001008844.3 | c.3583-1285_3583-1283del | intron_variant | ||||
DSP | NM_001319034.2 | c.4050+1117_4050+1119del | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.5167_5169del | p.Glu1723del | inframe_deletion | 23/24 | 1 | NM_004415.4 | P2 | |
DSP | ENST00000418664.2 | c.3583-1285_3583-1283del | intron_variant | 1 | A2 | ||||
DSP | ENST00000710359.1 | c.4050+1117_4050+1119del | intron_variant | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152160Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
8
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251270Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135822
GnomAD3 exomes
AF:
AC:
11
AN:
251270
Hom.:
AF XY:
AC XY:
6
AN XY:
135822
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461886Hom.: 0 AF XY: 0.0000729 AC XY: 53AN XY: 727246
GnomAD4 exome
AF:
AC:
97
AN:
1461886
Hom.:
AF XY:
AC XY:
53
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74318
GnomAD4 genome
AF:
AC:
8
AN:
152160
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74318
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 14, 2015 | The p.Glu1721[2] variant in DSP has not been previously reported in individuals with cardiomyopathy, but has been identified in 2/66410 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). This va riant deletes one of 3 glutamic acid residues (first unit at positions 1721-1723 ). It is unclear if this change will have an impact on protein function. In summ ary, the clinical significance of the p.Glu1721[2] variant is uncertain. - |
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 09, 2022 | This variant, c.5167_5169del, results in the deletion of 1 amino acid(s) of the DSP protein (p.Glu1723del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs730880091, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with DSP-related conditions. ClinVar contains an entry for this variant (Variation ID: 199944). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 02, 2023 | This variant causes a deletion of one amino acid in the DSP protein. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 13/282666 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 28, 2018 | The c.5167_5169delGAA variant results in an in-frame deletion of a glutamic acid (E) residue at position 1723. This variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. However, c.5167_5169delGAA has been classified in ClinVar as a variant of uncertain significance by an external laboratory (SCV000271732.1; Landrum et al., 2016). In addition, c.5167_5169delGAA has been observed in one other individual referred to GeneDx for cardiomyopathy testing and segregated with a DCM phenotype in three affected family members. Furthermore, this variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Other in-frame deletions in the DSP gene have been reported in HGMD in association with cardiomyopathy (Stenson et al., 2014), and at least two in silico models predict this amino acid deletion is probably damaging to the protein structure/function. Nonetheless, this variant lacks functional evidence and observation in a significant number of affected individuals, which would further clarify pathogenicityTherefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. - |
Primary familial hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Blueprint Genetics | Nov 05, 2014 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.5167_5169delGAA variant (also known as p.E1723del) is located in coding exon 23 of the DSP gene. This variant results from an in-frame GAA deletion at nucleotide positions 5167 to 5169. This results in the in-frame deletion of a glutamic acid at codon 1723. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at